By Professor Glenda Halliday

Journal articles

Halliday GM; Del Tredici K; Braak H, 2006, 'Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson`s disease', Journal of Neural Transmission - Supplement, pp. 99 - 103

Gregory GC; Macdonald V; Schofield PR; Kril J; Halliday GM, 2006, 'Differences in regional brain atrophy in genetic forms of Alzheimer's disease', Neurobiology of Aging, 27, pp. 387 - 393

Halliday GM; Fedorow HS; Rickert C; Gerlach M; Riederer P; Double KL, 2006, 'Evidence for specific phases in the development of human neuromelanin', Journal of Neural Transmission, 113, pp. 721 - 728

Shepherd CE; Goyette JD; Utter V; Rahimi F; Yang Z; Geczy C; Halliday GM, 2006, 'Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease', Neurobiology of Aging, 27, pp. 1554 - 1563

Fedorow HS; Pickford R; Kettle E; Cartwright M; Halliday GM; Gerlach M; Riederer P; Garner B; Double KL, 2006, 'Investigation of the lipid component of neuromelanin', Journal of Neural Transmission, 113, pp. 735 - 739

Pickering-Brown S; Baker M; Gass J; Boeve B; Loy CT; Brooks WS; Mackenzie IR; Martins RN; Kwok JB; Halliday GM; Kril J; Schofield PR; Mann DM; Hutton M, 2006, 'Mutations in progranulin explain atypical phenotypes with variants in MAPT', Brain, 129, pp. 3124 - 3126

Halliday GM; Song YC; Creasey H; Morris JC; Brooks WS; Kril J, 2006, 'Neuropathology in the S305S tau gene mutation', Brain, 129, pp. E40 - E40

Double KL; Halliday GM, 2006, 'New face of neuromelanin', Journal of Neural Transmission, pp. 119 - 123

Baker K; Huang Y; Mccann H; Gai WP; Jensen PH; Halliday GM, 2006, 'P25 alpha immunoreactive but alpha-synuclein immunonegative neuronal inclusions in multiple system atrophy', ACTA Neuropathologica, 111, pp. 193 - 195

Piguet O; Bennett HP; Waite LM; Kril J; Creasey H; Broe T; Halliday GM, 2006, 'Preserved Cognition and Functional Independence after a Large Right Posterior Cerebral Artery Infarct: Longitudinal Clinical and Neuropathological Findings', Neurocase, 12, pp. 81 - 90

Davies R; Kipps CM; Mitchell J; Kril J; Halliday GM; Hodges JR, 2006, 'Progression in frontotemporal dementia: Identifying a benign behavioral variant by magnetic resonance imaging', Archives of Neurology, 63, pp. 1627 - 1631

Halliday G, 2006, 'S2–02–04: The status of a–synuclein in Alzheimer cases with and without Lewy bodies', Alzheimer's & Dementia, 2, http://dx.doi.org/10.1016/j.jalz.2006.05.084

Götz J; David D; Ittner L; Halliday G; Shepherd C, 2006, 'S5–03–01: Animal and cellular models – tau–Abeta interaction', Alzheimer's & Dementia, 2, http://dx.doi.org/10.1016/j.jalz.2006.05.362

Kersaitis C; Halliday GM; Xuereb J; Pamphlett R; Bak T; Hodges JR; Kril J, 2006, 'Ubiquitin-positive inclusions and progression of pathology in frontotemporal dementia and motor neuron disease identifies a group with mainly early pathology', Neuropathology and Applied Neurobiology, 32, pp. 83 - 91

Halliday GM, 2005, 'Activation of molecular adaptation to sunlight - A new approach to photoprotection', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 125, pp. XVIII - XIX, http://dx.doi.org/10.1111/j.0022-202X.2005.23940.x

Byrne SN; Halliday GM, 2005, 'B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 124, pp. 570 - 578, http://dx.doi.org/10.1111/j.0022-202X.2005.23615.x

Kuchel J; Barnetson R; Zhuang L; Strickland F; Pelley R; Halliday G, 2005, 'Tamarind Inhibits Solar-Simulated Ultraviolet Radiation-Induced Suppression of Recall Responses in Humans', Letters in Drug Design & Discovery, 2, pp. 165 - 171, http://dx.doi.org/10.2174/1570180053175106

Osborne PB; Halliday GM; Cooper HM; Keast JR, 2005, 'Localization of immunoreactivity for deleted in colorectal cancer (DCC), the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents', Neuroscience, 131, pp. 671 - 681, http://dx.doi.org/10.1016/j.neuroscience.2004.11.043

Demangel C; Zhou J; Choo ABH; Shoebridge G; Halliday GM; Britton WJ, 2005, 'Single chain antibody fragments for the selective targeting of antigens to dendritic cells', Molecular Immunology, 42, pp. 979 - 985, http://dx.doi.org/10.1016/j.molimm.2004.09.034

Halliday GM; Macdonald V; Henderson JM, 2005, 'A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson`s disease', Brain, 128, pp. 2272 - 2280

Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM, 2005, 'A possible role for humoral immunity in the pathogenesis of Parkinson`s disease', Brain, 128, pp. 2665 - 2674

Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow HS; Cartwright M; Griffiths F; Shepherd CE; Double KL, 2005, 'alpha-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson`s disease', Brain, 128, pp. 2654 - 2664

Halliday GM, 2005, 'Clarifying Lewy-body parkinsonism with visual hallucinations', Lancet Neurology, 4, pp. 588 - 589, http://www.sciencedirect.com/science/article/B6X3F-4H45CPY-3/2/d0658ca7b44b7d4ecad2a629a838549c

Cordato N; Duggins A; Halliday GM; Morris JG; Pantelis C, 2005, 'Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy', Brain, 128, pp. 1259 - 1266

McKeith IG; Dickson DW; Lowe J; Emre M; O Brien J; Feldman H; Cummings J; Duda JE; Lippa C; Perry EK; Aarsland D; Arai H; Ballard CG; Boeve B; Burn D; Costa D; Del Ser T; Dubois B; Galasko D; Gauthier S; Goetz CG; Gomez-Tortosa E; Halliday GM; Hansen L; Hardy J; Iwatsubo T; Kalaria RN; kaufer D; Kenny RA; Korczyn A; Kosaka K; Lee V; Lees A; Litvan I; Londos E; Lopez O; Minoshima S; Mizuno Y; Molina JA; Mukaetova-Ladinska EB; Pasquier F; Perry RH; Schulz JB; Trojanowski JQ; Yamada M, 2005, 'Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium.', Neurology, 65, pp. 1863 - 1872

Li J; Scheller C; Koutsilieri E; Griffiths F; Beart PM; Mercer L; Halliday GM; Kettle E; Rowe DB; Riederer P; Gerlach M; Rodriguez M; Double KL, 2005, 'Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells', Journal of Neurochemistry, 95, pp. 599 - 608

Kril J; Macdonald V; Patel S; Png F; Halliday GM, 2005, 'Distribution of brain atrophy in behavioral variant frontotemporal dementia', Journal of the Neurological Sciences, 232, pp. 83 - 90, http://www.sciencedirect.com/science/article/B6T06-4FV366B-2/2/4d8e5edbf20b0dee1ab507d7748b65dd

Fedorow HS; Pickford R; Hook JM; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B, 2005, 'Dolichol is the major lipid component of human substantia nigra neuromelanin', Journal of Neurochemistry, 92, pp. 990 - 995

Kwok JB; Hallupp M; Loy CT; Chan DK; Woo J; Mellick GD; Buchanan D; Silburn PA; Halliday GM; Schofield PR, 2005, 'GSK3B polymorphisms alter transcription and splicing in Parkinson`s disease', Annals of Neurology, 58, pp. 829 - 839

Halliday GM; Lepar G; Harding AJ; Kwok JBJ, 2005, 'Inheritance of dementia with Lewy bodies: comment and review of the literature', Current Trends in Neurology, 1, pp. 51 - 66

Broe M; Shepherd CE; Mann DM; Milward EA; Gai WP; Kettle E; Halliday GM, 2005, 'Insoluble alpha-synuclein in Alzheimer's disease without Lewy body formation', Neurotoxicity Research, 7, pp. 69 - 76

Fedorow HS; Tribl F; Halliday GM; Gerlach M; Riederer P; Double KL, 2005, 'Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson`s disease', Progress in Neurobiology, 75, pp. 109 - 124

Shepherd CE; Gregory GC; Vickers J; Halliday GM, 2005, 'Novel 'inflammatory plaque' pathology in presenelin-1 Alzheimer's disease', Neuropathology and Applied Neurobiology, 31, pp. 503 - 511

Huang Y; Garrick R; Cook R; O Sullivan DJ; Morris JG; Halliday GM, 2005, 'Pallidal stimulation reduces treatment-induced dyskinesias in `minimal-change` multiple system atrophy', Movement Disorders, 20, pp. 1042 - 1047

Graham A; Davies R; Xuereb J; Halliday GM; Kril J; Creasey H; Graham K; Hodges JR, 2005, 'Pathologically proven frontotemporal dementia presenting with severe amnesia', Brain, 128, pp. 597 - 605

Raftery MJ; Campbell R; Glaros EN; Rye K; Halliday GM; Jessup W; Garner B, 2005, 'Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro.', Biochemistry, 44, pp. 7346 - 7353

Halliday GM; Song YC; Lepar GS; Brooks WS; Kwok JB; Kersaitis C; Gregory GC; Shepherd CE; Rahimi F; Schofield PR; Kril J, 2005, 'Pick bodies in a family with presenilin-1 Alzheimer's disease', Annals of Neurology, 57, pp. 139 - 143

Schofield EC; Caine D; Kril J; Cordato N; Halliday GM, 2005, 'Staging disease severity in movement disorder tauopathies: Brainatrophy separates progressive supranuclear palsy from corticobasaldegeneration', Movement Disorders, 20, pp. 34 - 39

Halliday GM, 2005, 'The emergence of proto-objects in complex visual hallucinations', Behavioral and Brain Sciences, 28, pp. 767 - 768

Davies R; Hodges JR; Kril J; Patterson K; Halliday GM; Xuereb J, 2005, 'The pathological basis of semantic dementia', Brain, 128, pp. 1984 - 1995

Gregory GC; Halliday GM, 2005, 'What is the dominant A beta species in human brain tissue? A review', Neurotoxicity Research, 7, pp. 29 - 41

Barnetson RSC; Satchell A; Zhuang L; Slade HB; Halliday GM, 2004, 'Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells', CLINICAL AND EXPERIMENTAL DERMATOLOGY, 29, pp. 639 - 643, http://dx.doi.org/10.1111/j.1365-2230.2004.01614.x

Duma S; Chalkley S; Halliday G; Broe GA, 2004, 'The role of the pre-SMA in age related gait disorder', AUSTRALASIAN JOURNAL ON AGEING, 23, pp. A49 - A50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208445000159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hersey P; Menzies SW; Halliday GM; Nguyen T; Farrelly ML; DeSilva C; Lett M, 2004, 'Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma', Cancer Immunology, Immunotherapy, 53, pp. 125 - 134, http://dx.doi.org/10.1007/s00262-003-0429-0

Meredith G; Halliday GM; Totterdell S, 2004, 'A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson`s disease: new insights into Lewy body formation', Parkinsonism and Related Disorders, 10, pp. 191 - 202

Aarsland D; Ballard C; Halliday GM, 2004, 'Are Parkinson`s disease with dementia and dementia with Lewy bodies the same entity?', Journal of Geriatric Psychiatry and Neurology, 17, pp. 137 - 145

Broe M; Kril J; Halliday GM, 2004, 'Astrocytic degeneration relates to the severity of disease infrontotemporal dementia', Brain, 127, pp. 2214 - 2220

Hodges JR; Davies R; Xuereb J; Casey B; Broe M; Bak T; Kril J; Halliday GM, 2004, 'Clinicopathological correlates in frontotemporal dementia', Annals of Neurology, 56, pp. 399 - 406

Kril J; Halliday GM, 2004, 'Clinicopathological staging of frontotemporal dementia severity: correlation with regional atrophy', Dementia and Geriatric Cognitive Disorders, 17, pp. 311 - 315

Mckeith IG; Mintzer J; Aarsland D; Burn D; Chiu H; Cohen-Mansfield J; Dickson D; Dubois B; Dua JE; Feldman H; Gauthier S; Halliday GM; Lawlor B; Lippa C; Lopez O; Machado JC; O Brien J; Playfer J; Reid WG, 2004, 'Dementia with Lewy bodies', Lancet Neurology, 3, pp. 19 - 28

Back to profile page